Open AccessA one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
Author(s) -
Fen-Yu Ren
Publication year - 2007
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v13.i31.4264
Subject(s) - entecavir , lamivudine , medicine , hbeag , gastroenterology , nucleoside analogue , hepatitis b , hepatitis b virus , serology , liver function , chronic hepatitis , refractory (planetary science) , nucleoside , immunology , virus , hbsag , biology , antibody , biochemistry , astrobiology
To evaluate the efficacy and safety of entecavir (ETV) in hepatitis Be antigen (HBeAg)-positive chronic hepatitis B (CHB) patients who had not received a nucleoside analogue and who had failed in lamivudine (LVD) therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom